Your browser doesn't support javascript.
loading
Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination.
Vadrevu, Krishna Mohan; Raju, Dugyala; Rani, Sandhya; Reddy, Siddharth; Sarangi, Vamshi; Ella, Raches; Javvaji, Bhuvaneswara; Mahantshetty, Niranjana S; Battu, Sudhakar; Levine, Myron M.
Afiliação
  • Vadrevu KM; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
  • Raju D; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
  • Rani S; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
  • Reddy S; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
  • Sarangi V; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
  • Ella R; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India. Electronic address: ellar@bharatbiotech.com.
  • Javvaji B; Sri Srinivasa Children's Hospital, Vijayawada, India.
  • Mahantshetty NS; Priya Children's Hospital, Vijayawada, India.
  • Battu S; KLE Hospital, Belgavi, India.
  • Levine MM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, USA.
Vaccine ; 39(45): 6682-6690, 2021 10 29.
Article em En | MEDLINE | ID: mdl-34625288

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Tifoide / Vacinas Tíficas-Paratíficas Tipo de estudo: Risk_factors_studies Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Tifoide / Vacinas Tíficas-Paratíficas Tipo de estudo: Risk_factors_studies Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article